美国FDA生物制品紫皮书数据库
(U.S. FDA Purple Book: Database of Licensed Biological Products)
商品名 申请号 产品号 BLA类型 非专利名称 剂型 给药途径 规格/剂量 产品形式 批准日期 申请人 市场状态 许可证状态 参考产品非专利名称 参考产品专利名称
Humate-P 103960 003 351(a) Antihemophilic Factor/von Willebrand Factor Complex (Human) For Injection Intravenous 500IU Single-Dose Vial 2000/04/11 CSL Behring GmbH Rx Licensed N/A
Albuminar, Albuminar-20, Albuminar-25, Albuminar-5 103955 001 351(a) Albumin (Human) Injection Intravenous 10G/50ML Single-Dose Vial 2000/03/17 CSL Behring LLC Disc Voluntarily Revoked N/A
Albuminar, Albuminar-20, Albuminar-25, Albuminar-5 103955 002 351(a) Albumin (Human) Injection Intravenous 20G/100ML Single-Dose Vial 2000/03/17 CSL Behring LLC Disc Voluntarily Revoked N/A
Albuminar, Albuminar-20, Albuminar-25, Albuminar-5 103955 004 351(a) Albumin (Human) Injection Intravenous 5G/20ML Single-Dose Vial 2000/03/17 CSL Behring LLC Disc Voluntarily Revoked N/A
Albuminar, Albuminar-20, Albuminar-25, Albuminar-5 103955 005 351(a) Albumin (Human) Injection Intravenous 2.5G/50ML Single-Dose Vial 2000/03/17 CSL Behring LLC Disc Voluntarily Revoked N/A
gammar i.v.,gammar-p i.v. 103956 001 351(a) Immune Globulin Intravenous (Human) For Injection Intravenous 10G Vial 2000/03/17 CSL Behring LLC Disc Voluntarily Revoked
gammar i.v.,gammar-p i.v. 103956 002 351(a) Immune Globulin Intravenous (Human) For Injection Intravenous 5G Vial 2000/03/17 CSL Behring LLC Disc Voluntarily Revoked
gammar i.v.,gammar-p i.v. 103956 003 351(a) Immune Globulin Intravenous (Human) For Injection Intravenous 2.5G Vial 2000/03/17 CSL Behring LLC Disc Voluntarily Revoked
gammar i.v.,gammar-p i.v. 103956 004 351(a) Immune Globulin Intravenous (Human) For Injection Intravenous 1G Vial 2000/03/17 CSL Behring LLC Disc Voluntarily Revoked
Mononine 103957 001 351(a) Coagulation Factor IX (Human) For Injection Intravenous 1000IU Single-Dose Vial 2000/03/17 CSL Behring LLC Disc Voluntarily Revoked N/A
Mononine 103957 002 351(a) Coagulation Factor IX (Human) For Injection Intravenous 500IU Single-Dose Vial 2000/03/17 CSL Behring LLC Disc Voluntarily Revoked N/A
103937 001 351(a) Botulism Antitoxin Bivalent (Equine) Types A and B. Injection Intravenous 5000IU Vial 2000/02/24 Sanofi Pasteur Limited Rx Voluntarily Revoked
Poliovax 103940 001 351(a) Poliovirus Vaccine Inactivated (Human Diploid Cell) Injection Subcutaneous 0.5ML Vial 2000/02/24 Sanofi Pasteur Limited Disc Licensed N/A
Poliovax 103940 002 351(a) Poliovirus Vaccine Inactivated (Human Diploid Cell) Injection Intramuscular 0.5ML Vial 2000/02/24 Sanofi Pasteur Limited Disc Licensed N/A
Tubersol 103941 001 351(a) Tuberculin, Purified Protein Derivative Injection Intradermal 5TU/.1ML Multi-Dose Vial 2000/02/24 Sanofi Pasteur Limited Rx Licensed N/A
Mycobax 103942 001 351(a) BCG Vaccine For Injection Intradermal 1.5MG Multi-Dose Vial 2000/02/24 Sanofi Pasteur Limited Rx Voluntarily Revoked
TheraCys 103943 001 351(a) BCG Live For Injection Intravesical 81MG Vial 2000/02/24 Sanofi Pasteur Limited Rx Voluntarily Revoked
103944 001 351(a) Diphtheria & Tetanus Toxoids Adsorbed Injection Intramuscular 25/LF/5LF/0.5ML Single-Dose Vial 2000/02/24 Sanofi Pasteur Limited Disc Voluntarily Revoked N/A
prevnar 103905 001 351(a) Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein) Injection Intramuscular 0.5ML/VIAL Pre-Filled Syringe 2000/02/17 Wyeth Pharmaceuticals LLC Rx Voluntarily Revoked
Ipol 103930 001 351(a) Poliovirus Vaccine Inactivated Injection Intramuscular 32/40/8 DAU/.5ML Multi-Dose Vial 2000/02/04 Sanofi Pasteur SA Rx Licensed N/A
当前数据更新日期:2025年12月17日,更多信息请点击此处查询美国FDA药品数据库

数据库说明:

©2006-2025 DrugFuture->U.S. FDA Purple Book